Due in large part to the effective deployment of prescription drug monitoring programs (PDMPs), opioid prescribing is at a 10-year low. Unfortunately, with overdose deaths at an all-time high, it is clear that tracking the dispensing of controlled substances is necessary but not sufficient to support prescribing decisions that lead to a reduction in substance use disorders.
hc1 Opioid Advisor, delivered via a strategic partnership with Appriss Health, was thoughtfully designed to comply with state PDMP regulations and to satisfy state-mandated use laws. The solution automatically compares toxicology results with PDMP data, providing clinical decision support to personalize prescribing of controlled substances, including opioids.
hc1 Opioid Advisor connects with the laboratory information system to perform an intelligent consistency analysis of toxicology results compared to the PDMP data in real-time. This breakthrough clinical decision support solution automatically does the work of a smart pharmacist by delivering an intelligent drug consistency assessment on-demand, in real-time, that includes risk scores, red flags, and access to the full state PDMP report, including access to adjacent state PDMP reports. Through a seamless clinical workflow, physicians can quickly identify aberrant behaviors, non-compliance, and overdose risk while fulfilling state requirements for checking the PDMP.
hc1 Opioid Advisor enables laboratories to: